Josef S. Smolen
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 518 publications
Ultrasound-based withdrawal of biologics in rheumatoid arthritis (RA-BioStop).
Journal: RMD open
Published: March 30, 2026
Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA Trials.
Journal: Joint bone spine
Published: February 24, 2026
Certolizumab inhibits radiographic progression in patients with early rheumatoid arthritis and high rheumatoid factor levels: A pooled, post-hoc analysis of the phase 3 C-EARLY and C-OPERA trials.
Journal: Joint bone spine
Published: February 24, 2026
Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force.
Journal: Annals of the rheumatic diseases
Published: February 16, 2026
Further Validation of a Questionnaire to Assess Flare in Psoriatic Arthritis: Determination of Cutoff and Longitudinal Change.
Journal: The Journal of rheumatology
Published: February 05, 2026
Greetings from the editor-2026.
Journal: Annals of the rheumatic diseases
Published: December 26, 2025
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).
Journal: Rheumatology and therapy
Published: December 08, 2025
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: December 08, 2025
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: December 02, 2025
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.
Journal: Annals of the rheumatic diseases
Published: November 21, 2025
Response to 'Correspondence on 'Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update' by Nash et al.' by Telliez et al.
Journal: Annals of the rheumatic diseases
Published: November 10, 2025
Last Updated: 09/26/2026